![](/img/cover-not-exists.png)
Treatment of myelodysplastic syndromes with 5q deletion before the lenalidomide era; the GFM experience with EPO and thalidomide
C. Kelaidi, S. Park, S. Brechignac, L. Mannone, N. Vey, H. Dombret, L. Aljassem, A. Stamatoullas, L. Adès, S. Giraudier, S. de Botton, S. Raynaud, P. Lepelley, F. Picard, G. Leroux, M.T. Daniel, D. BoVolume:
32
Year:
2008
Language:
english
Pages:
5
DOI:
10.1016/j.leukres.2007.11.037
File:
PDF, 98 KB
english, 2008